Manufacture

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

So much has already been achieved with RNA – and it’s only going to get better.

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Doing more to ease the challenges of antibody drug conjugate manufacturing.